Featured Research

from universities, journals, and other organizations

Drug kills cells through novel mechanism

Date:
December 17, 2009
Source:
Massachusetts Institute of Technology
Summary:
Researchers have discovered that the drug hydroxyurea kills bacteria by inducing them to produce molecules toxic to themselves -- a conclusion that raises the possibility of finding new antibiotics that use similar mechanisms.

MIT and Boston University researchers have discovered that the drug hydroxyurea kills bacteria by inducing them to produce molecules toxic to themselves -- a conclusion that raises the possibility of finding new antibiotics that use similar mechanisms.

Related Articles


Hydroxyurea inhibits the enzyme critical for making the building blocks for DNA, so for decades it has been used to study the consequences of inhibiting DNA replication in E. coli, yeast and mammalian cells. It is also sometimes used in chemotherapy to halt the growth of cancer cells.

The research team, led by biologist Graham Walker of MIT and bioengineer James Collins of Boston University, showed that cells don't die after hydroxyurea treatment because their DNA replication is blocked, but because the blockage sets in motion a chain of cellular events that culminates in the production of hydroxyl radicals. Those radicals are highly reactive and can damage cellular molecules such as nucleic acids, lipids and proteins.

Collins has previously shown that three different antibiotics, which each inhibit different cell processes, all lead to production of hydroxyl radicals, which play a role in killing the cells.

"This naturally leads to the thought that one could perhaps find a new class of antibiotic that acts further down the chain(s) of events that stimulate hydroxyl radical production," says Walker.

The findings could also aid in the development of adjuvants -- small molecules that would enhance the lethality of current antibiotics, says Collins.

The researchers exposed E. coli to hydroxyurea, provoking them to activate a DNA repair system called SOS. This response keeps the cells alive for several hours, but eventually produces hydroxyl radicals that kill the bacteria.

Next steps: In future studies, Walker hopes to delve further into the mechanism of bacterial response to hydroxyrurea and the sequence of events that ultimately kills them.

Funding: National Institutes of Health, Howard Hughes Medical Institute, National Science Foundation, National Sciences and Engineering Research Council of Canada, National Cancer Institute, MIT Center for Environmental Health Sciences.


Story Source:

The above story is based on materials provided by Massachusetts Institute of Technology. The original article was written by Anne Trafton, MIT News Office. Note: Materials may be edited for content and length.


Journal Reference:

  1. Bryan Davies et al. Hydroxyurea Induces Hydroxyl Radical-Mediated Cell Death in Escherichia coli. Molecular Cell, Dec. 11, 2009

Cite This Page:

Massachusetts Institute of Technology. "Drug kills cells through novel mechanism." ScienceDaily. ScienceDaily, 17 December 2009. <www.sciencedaily.com/releases/2009/12/091210125920.htm>.
Massachusetts Institute of Technology. (2009, December 17). Drug kills cells through novel mechanism. ScienceDaily. Retrieved November 1, 2014 from www.sciencedaily.com/releases/2009/12/091210125920.htm
Massachusetts Institute of Technology. "Drug kills cells through novel mechanism." ScienceDaily. www.sciencedaily.com/releases/2009/12/091210125920.htm (accessed November 1, 2014).

Share This



More Health & Medicine News

Saturday, November 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Melafind: Spotting Melanoma Without a Biopsy

Melafind: Spotting Melanoma Without a Biopsy

Ivanhoe (Oct. 31, 2014) The MelaFind device is a pain-free way to check suspicious moles for melanoma, without the need for a biopsy. Video provided by Ivanhoe
Powered by NewsLook.com
Battling Multiple Myeloma

Battling Multiple Myeloma

Ivanhoe (Oct. 31, 2014) The answer isn’t always found in new drugs – repurposing an ‘old’ drug that could mean better multiple myeloma treatment, and hope. Video provided by Ivanhoe
Powered by NewsLook.com
Chronic Inflammation and Prostate Cancer

Chronic Inflammation and Prostate Cancer

Ivanhoe (Oct. 31, 2014) New information that is linking chronic inflammation in the prostate and prostate cancer, which may help doctors and patients prevent cancer in the future. Video provided by Ivanhoe
Powered by NewsLook.com
Sickle Cell: Stopping Kids’ Silent Strokes

Sickle Cell: Stopping Kids’ Silent Strokes

Ivanhoe (Oct. 31, 2014) Blood transfusions are proving crucial to young sickle cell patients by helping prevent strokes, even when there is no outward sign of brain injury. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins